Why is this ASX 200 stock crashing 30% today?

What's going with this stock? Let's find out why its shares are deep in the red.

| More on:
A man holds his head in his hands, despairing at the bad result he's reading on his computer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healius Ltd (ASX: HLS) shares are ending the week deep in the red.

In morning trade, the ASX 200 stock is down 30% to a 52-week low of $1.07.

As a comparison, the benchmark ASX 200 index is up 0.15% at the time of writing.

Why is this ASX 200 stock crashing 30%?

The good news for shareholders is that today's massive decline in the Healius share price is not because of a bad update nor a broker downgrade.

In fact, today's big decline could arguably be good news for them.

That's because the decline has been driven by the healthcare company's shares going ex-dividend this morning for a very special dividend.

When a share goes ex-dividend, it means that the rights to an upcoming dividend payment are now settled. As a result, anyone buying this ASX 200 stock today will not be entitled to receive the Healius dividend when it is paid to shareholders. Instead, it will stay with the seller of the shares even though they no longer own them.

In light of this, a share price will usually drop to reflect this. After all, you don't want to pay for something that you won't receive.

The Healius dividend

Earlier this week, Healius announced plans to pay a special dividend following the completion of the sale of Lumus Imaging to funds managed by Affinity Equity Partners.

The ASX 200 stock received cash proceeds of $822 million, which represented an $965 million enterprise value when adjusted for the repayment of equipment leases and closing adjustments.

Net proceeds are expected to be in excess of $800 million after all transaction fees, separation costs and other fees.

Unfortunately, not all of these funds will be returned to shareholders, but a good portion will be.

The ASX 200 stock is returning $300 million to shareholders through a fully franked special dividend of 41.3 cents per share. Those franking credits equate to 17.7 cents per share or approximately $128 million.

Based on where the Healius share price finished yesterday's session, this equates to a stunning 26.8% fully franked dividend yield.

To put that into context, a $5,000 investment in its shares yesterday would generate approximately $1,340 in dividends.

When is pay day?

The ASX 200 stock's eligible shareholders won't have to wait long for pay day.

The healthcare company is planning to pay this monster dividend to shareholders in two weeks on 23 May.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

After soaring 40% in 2 weeks, this ASX All Ords healthcare stock has been downgraded

Here’s what analysts at Macquarie rate the stock as now.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Own NIB shares? Here are the key dates for 2026

NIB has released its corporate calendar, including dividend dates, for 2026.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

ASX healthcare stock debuts at a massive discount to its initial public offer price

Saluda Medical shares have had a difficult start to public life, trading well below the initial public offer price.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Healthcare Shares

Why CSL shares now look 'massively oversold'

A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Which junior biotech's shares are flying on positive trial news?

This company's shares have surged higher after positive clinical trial results for its stroke treatment drug.

Read more »

Excited elderly woman on a swing.
Healthcare Shares

Guess which ASX 300 healthcare share is lifting off on $25 million news

The ASX 300 healthcare share is grabbing investor interest on Thursday. Let’s see why.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Doomed takeover bid for Mayne Pharma to come to an end

The Mayne Pharma takeover saga appears to be finally drawing to an end, with shareholders bearing the pain of the…

Read more »